Literature DB >> 11134592

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

K Yasojima1, C Schwab, E G McGeer, P L McGeer.   

Abstract

C-reactive protein (CRP) and amyloid P (AP) are pentraxins which are associated with many pathological lesions, including the amyloid deposits and neurofibrillary tangles (NFTs) of Alzheimer disease (AD). It has always been assumed that they are generated by liver and delivered to their sites of action by serum. Here we report by in situ hydridization, reverse transcriptase-polymerase chain reaction analysis, Western blotting and immunohistochemistry that the mRNAs and proteins of both CRP and AP are concentrated in pyramidal neurons and are upregulated in affected areas of AD brain. Controlling pentraxin production at the tissue level may be important in reducing inflammatory damage in AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134592     DOI: 10.1016/s0006-8993(00)02970-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  78 in total

Review 1.  Local neuroinflammation and the progression of Alzheimer's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

4.  Inflammatory markers and neuropsychological functioning: the Framingham Heart Study.

Authors:  Angela L Jefferson; Joseph M Massaro; Alexa S Beiser; Sudha Seshadri; Martin G Larson; Philip A Wolf; Rhoda Au; Emelia J Benjamin
Journal:  Neuroepidemiology       Date:  2011-07-13       Impact factor: 3.282

5.  C-reactive protein in vulnerable coronary plaques.

Authors:  Silja Norja; Lauri Nuutila; Pekka J Karhunen; Sirkka Goebeler
Journal:  J Clin Pathol       Date:  2006-06-21       Impact factor: 3.411

6.  Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.

Authors:  Simon E Kolstoe; Basil H Ridha; Vittorio Bellotti; Nan Wang; Carol V Robinson; Sebastian J Crutch; Geoffrey Keir; Riitta Kukkastenvehmas; J Ruth Gallimore; Winston L Hutchinson; Philip N Hawkins; Stephen P Wood; Martin N Rossor; Mark B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

7.  Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer's disease.

Authors:  Huan-Bing Lin; Xue-Mei Yang; Tie-Jun Li; Yu-Fang Cheng; Han-Ting Zhang; Jiang-Ping Xu
Journal:  Psychopharmacology (Berl)       Date:  2009-03-05       Impact factor: 4.530

8.  CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein.

Authors:  M W Miller; H Maniates; E J Wolf; M W Logue; S A Schichman; A Stone; W Milberg; R McGlinchey
Journal:  Brain Behav Immun       Date:  2017-09-01       Impact factor: 7.217

9.  Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop.

Authors:  Sridevi Devaraj; Natalie Torok; Mohan R Dasu; David Samols; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

Review 10.  Glial cell dysregulation: a new perspective on Alzheimer disease.

Authors:  Rommy von Bernhardi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.